Evidence map›Paper›PMID 26057084›Full record

ArticleNeurobiology of disease2015

Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.

Iram Ahmad, Augusta Fernando, Richard Gurgel, J Jason Clark, Linjing Xu, Marlan R Hansen

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.Molecular therapy. Methods & clinical development · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Photopolymerized Microfeatures Guide Adult Spiral Ganglion and Dorsal Root Ganglion Neurite Growth.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2018
    Article
  12. Article
  13. Review
  14. STAT3 Controls the Long-Term Survival and Phenotype of Repair Schwann Cells during Nerve Regeneration.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Iram AhmadDepartment of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, IA 52242, USA.
Augusta FernandoDepartment of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, IA 52242, USA.
Richard GurgelDepartment of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, IA 52242, USA.
J Jason ClarkDepartment of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, IA 52242, USA.
Linjing XuDepartment of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, IA 52242, USA.
Marlan R HansenDepartment of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, IA 52242, USA; Department of Neurosurgery, University of Iowa, Iowa City, IA 52242, USA. Electronic address: marlan-hansen@uiowa.edu.
University of Iowa · US

Funding

Research Training Program in OtolaryngologyT32DC000040 · NIDCD · UNIVERSITY OF IOWA · PI HANSEN, MARLAN R · 1993 to 2025
$5.4M
Tissue Culture CoreP30DC010362 · NIDCD · UNIVERSITY OF IOWA · PI EBERL, DANIEL F, LOGSDON, JOHN M · 2010 to 2014
$2.0M
Contribution of c-Jun N-terminal kinase activity to vestibular schwannoma growthR01DC009801 · NIDCD · UNIVERSITY OF IOWA · PI HANSEN, MARLAN R · 2009 to 2013
$1.8M
NIDCD NIH HHS P30 DC010362NIDCD NIH HHS P30DC010362NIDCD NIH HHS R01 DC009801NIDCD NIH HHS R01DC009801NIDCD NIH HHS T32 DC000040NIDCD NIH HHS T32DC000040
6 · The paper itself

Abstract

After nerve injury, Schwann cells (SCs) dedifferentiate, proliferate, and support axon regrowth. If axons fail to regenerate, denervated SCs eventually undergo apoptosis due, in part, to increased expression of the low-affinity neurotrophin receptor, p75(NTR). Merlin is the protein product of the NF2 tumor suppressor gene implicated in SC tumorigenesis. Here we explore the contribution of merlin to SC responses to nerve injury. We find that merlin becomes phosphorylated (growth permissive) in SCs following acute axotomy and following gradual neural degeneration in a deafness model, temporally correlated with increased p75(NTR) expression. p75(NTR) levels are elevated in P0SchΔ39-121 transgenic mice that harbor an Nf2 mutation in SCs relative to wild-type mice before axotomy and remain elevated for a longer period of time following injury. Replacement of wild-type, but not phospho-mimetic (S518D), merlin isoforms suppresses p75(NTR) expression in primary human schwannoma cultures which otherwise lack functional merlin. Despite elevated levels of p75(NTR), SC apoptosis following axotomy is blunted in P0SchΔ39-121 mice relative to wild-type mice suggesting that loss of functional merlin contributes to SC resistance to apoptosis. Further, cultured SCs from mice with a tamoxifen-inducible knock-out of Nf2 confirm that SCs lacking functional merlin are less sensitive to p75(NTR)-mediated cell death. Taken together these results point to a model whereby loss of axonal contact following nerve injury results in merlin phosphorylation leading to increased p75(NTR) expression. Further, they demonstrate that merlin facilitates p75(NTR)-mediated apoptosis in SCs helping to explain how neoplastic SCs that lack functional merlin survive long-term in the absence of axonal contact.

Indexed as

AnimalsApoptosisAxonsAxotomyCell DedifferentiationCell ProliferationCells, CulturedHumansMiceMice, TransgenicNerve RegenerationNeurofibromin 2Neuroma, AcousticPeripheral Nerve InjuriesRats, Sprague-DawleyReceptor, Nerve Growth FactorNeurofibromin 2Receptor, Nerve Growth FactorAxotomyCell deathNerve growth factorNeurofibromatosis type 2ReceptorSchwann cells

Identifiers

PMID26057084
PMCPMC4641051
OpenAlexW574235218

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.